DJIA51682.64 -95.40
S&P 5007650.50 12.74
NASDAQ26522.55 104.25
Russell 20002860.40 -14.23
German DAX25304.06 -412.65
FTSE 10010659.13 -157.01
CAC 408065.02 -121.91
EuroStoxx 506228.55 -96.70
Nikkei 22565018.95 882.70
Hang Seng24750.78 146.49
Shanghai Comp3911.87 36.27
KOSPI6894.23 178.82
Bloomberg Comm IDX141.42 0.00
WTI Crude-fut98.77 -0.73
Brent Crude-fut95.47 -1.16
Natural Gas3.03 0.03
Gasoline-fut3.24 0.04
Gold-fut4415.90 34.20
Silver-fut66.79 1.01
Platinum-fut1804.60 26.40
Palladium-fut1314.50 23.50
Copper-fut6.72 0.10
Aluminum-spot3195.00 0.00
Coffee-fut277.20 0.45
Soybeans-fut1303.00 -16.50
Wheat-fut713.50 -12.25
Bitcoin81243.41 5183.97
Ethereum USD2630.17 222.32
Litecoin57.54 6.37
Dogecoin0.09 0.01
EUR/USD1.1470 -0.0078
USD/JPY155.88 0.82
GBP/USD1.3333 -0.0117
USD/CHF0.8237 0.0041
USD IDX100.21 -0.02
US 10-Yr TR4.998 0.051
GER 10-Yr TR3.519 -0.0027
UK 10-Yr TR5.2907 -0.0086
JAP 10-Yr TR2.985 0.009
Fed Funds4 0
SOFR3.85 0.23
Connect News Money news for every market and every facet, every day.
Connect Money Events Live and virtual events bringing together the best of information and networking.
Financial Industry Events Live industry events.
Connect Creative A full service marketing and PR agency.
Connect Awards View the A-list of money & submit nominations.
Connect Media Kit Advertise, Promote, Attend, Create – Work with Connect.
About Connect Meet the team behind the machine and taste a little of the secret sauce.
Connect News

Your source for clear, concise news of maximum importance to the financial services industry.

Connect Classroom

Offering on-demand online courses that provide continuing education credits for brokers, attorneys, appraisers and architects. Select from easily accessible video and written courses that cover a variety of CRE topics.

Find Your Course
High-rise commercial buildings

STAY INFORMED

News when you need it. All our Breaking News, right to your inbox.

Sub Markets

Topics

Alternative Assets  + VC  |  March 23, 2023
Artera Raise $90M for AI-Enabled Cancer Therapy
Joe Palmisano
By: Joe Palmisano

Artera Raise $90M for AI-Enabled Cancer Therapy

Artera, a CA-based startup that offers an AI-enabled test aimed at personalizing therapy for prostate cancer patients, has raised $90 million from technology and healthcare investors Johnson & Johnson, TIME Ventures, Koch Disruptive Technologies, Coatue, Walden Catalyst Ventures, The Factory, Breyer Capital and angel investors.

The company intends to use the funds to invest in the development of tests to support therapy personalization in other cancers.

Artera’s multimodal AI-powered test for prostate cancer patients, called ArteraAI Prostate Test, helps predict the potential benefits of therapy and a patient’s prognosis by analyzing the patient’s clinical data and biopsy images.

“The American Cancer Society estimates that more than 288,000 new cases of prostate cancer will arise in 2023, with more than 34,000 deaths. AI has given clinicians and patients a powerful weapon in the fight against this disease,” said Andre Esteva, co-founder and CEO of Artera.

Founded in 2015, Artera has now raised $135 million. The company was formerly known as Well Health and rebranded itself in October.

Connect

Inside The Story

Artera

About Joe Palmisano

Joe Palmisano is editorial director of Connect Money, where he oversees daily coverage of alternative assets, direct investments, financial advisory and the economy. He brings three decades of experience as a financial journalist, analyst and portfolio manager. Before joining Connect Money, Palmisano wrote for The Wall Street Journal, covering foreign exchange, global fixed-income and equity markets. He later served as a senior research analyst and portfolio manager, producing market analysis and managing foreign exchange and U.S. equity portfolios for FX Concepts. His work has also appeared in SFO Magazine and CMT Association publications. Palmisano earned a bachelor’s degree in finance from The American University and holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.
Order Reprints